- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14.08. | Tavneos trial flagged for 'serious breaches' of protocol as EU regulators dissect market withdrawal decision | ||
| 14.08. | BMS bags first FDA approval for CELMoD franchise with Zenbexus multiple myeloma nod | ||
| 14.08. | A genomics library for the AI era | ||
| 13.08. | It's crunch time for Karyopharm as company faces potential default next month | ||
| 13.08. | AstraZeneca's blood pressure newcomer Baxfendy fails to meet cost-effectiveness bar, ICER says | ||
| 13.08. | Obesity not a 'zero-sum game' as patients crave optionality, Novo CEO says: Reuters | ||
| 13.08. | Abbott to pump up blood supply with $1M college sports prize amid US crisis | ||
| 12.08. | Legend interim CEO talks rising competition as Carvykti maker posts first profit | ||
| 12.08. | Alfasigma gains arthritis drug, access to new markets with M&A play | ||
| 12.08. | Lilly takes 6 companies to court for selling retatrutide knockoffs | ||
| 12.08. | Fresenius pulls one batch of Actemra biosim over glass particle concerns | ||
| 12.08. | Snapchat creates ad format to support pharma disclosure needs | ||
| 11.08. | WuXi AppTec scores temporary win amid fight over DOD's Chinese military company brand | ||
| 11.08. | Attruby cruises toward blockbuster land as BridgeBio CEO spots 'stabilizer-first' ATTR market | ||
| 10.08. | Unapproved in US for decades, levosimendan stumbles in phase 3 as Tenax eyes narrow FDA path | ||
| 10.08. | Abbott casts telenovela star Gabriela Spanic to take the drama out of colon cancer screening | ||
| 10.08. | ITM neuroendocrine tumor drug spurned by FDA over manufacturing qualms | ||
| 10.08. | Bristol Myers Squibb lays out plan for $2.3B manufacturing facility in Houston | ||
| 10.08. | Scholar Rock ditches Novo's legacy Catalent plant in FDA refiling of SMA drug | ||
| 10.08. | Quanterix hires GE Healthcare, Exact Sciences alum as chief commercial officer | ||
| 07.08. | Lilly's Zepbound remains physicians' favorite, even as oral obesity launches altar landscape | ||
| 07.08. | AbbVie's Skyrizi retakes edge in pharma's July ad spending league | ||
| 07.08. | Novo Nordisk makes Omnicom agency of record for US media buying | ||
| 07.08. | Fresenius Kabi recalls mislabeled morphine lot that could cause overdose death | ||
| 06.08. | Replimune secures FDA approval for melanoma therapy Tudriqev after long regulatory battle |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.